Rallybio Statistics

Total Valuation

Rallybio has a market cap or net worth of $13.19 million. The enterprise value is -$41.02 million.

Market Cap	13.19M
Enterprise Value	-41.02M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Rallybio has 41.61 million shares outstanding. The number of shares has increased by 9.78% in one year.

Current Share Class	41.61M
Shares Outstanding	41.61M
Shares Change (YoY)	+9.78%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	4.16%
Owned by Institutions (%)	28.39%
Float	19.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.81
Forward PS	n/a
PB Ratio	0.25
P/TBV Ratio	0.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.68, with a Debt / Equity ratio of 0.00.

Current Ratio	14.68
Quick Ratio	13.94
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.28% and return on invested capital (ROIC) is -43.83%.

Return on Equity (ROE)	-67.28%
Return on Assets (ROA)	-40.02%
Return on Invested Capital (ROIC)	-43.83%
Return on Capital Employed (ROCE)	-93.17%
Revenue Per Employee	$33,920
Profits Per Employee	-$1.93M
Employee Count	25
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.68% in the last 52 weeks. The beta is -1.28, so Rallybio's price volatility has been lower than the market average.

Beta (5Y)	-1.28
52-Week Price Change	-79.68%
50-Day Moving Average	0.40
200-Day Moving Average	0.84
Relative Strength Index (RSI)	49.28
Average Volume (20 Days)	79,650

Short Selling Information

The latest short interest is 363,424, so 0.87% of the outstanding shares have been sold short.

Short Interest	363,424
Short Previous Month	351,626
Short % of Shares Out	0.87%
Short % of Float	1.85%
Short Ratio (days to cover)	1.89

Income Statement

In the last 12 months, Rallybio had revenue of $848,000 and -$48.19 million in losses. Loss per share was -$1.08.

Revenue	848,000
Gross Profit	-38.66M
Operating Income	-50.38M
Pretax Income	-73.88M
Net Income	-48.19M
EBITDA	-50.26M
EBIT	-50.38M
Loss Per Share	-$1.08

Full Income Statement

Balance Sheet

The company has $54.50 million in cash and $116,000 in debt, giving a net cash position of $54.38 million or $1.31 per share.

Cash & Cash Equivalents	54.50M
Total Debt	116,000
Net Cash	54.38M
Net Cash Per Share	$1.31
Equity (Book Value)	54.07M
Book Value Per Share	1.30
Working Capital	53.47M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-44.03M
Capital Expenditures	n/a
Free Cash Flow	-44.03M
FCF Per Share	-$1.06

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-5,940.92%
Pretax Margin	-5,682.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Rallybio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.78%
Shareholder Yield	-9.78%
Earnings Yield	-360.72%
FCF Yield	-329.61%

Analyst Forecast

The average price target for Rallybio is $15.00, which is 4,631.86% higher than the current price. The consensus rating is "Hold".

Price Target	$15.00
Price Target Difference	4,631.86%
Analyst Consensus	Hold
Analyst Count	3
Revenue Growth Forecast (5Y)	261.73%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Rallybio has an Altman Z-Score of -1.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.51
Piotroski F-Score	2